Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

VTU Media Coverage

IAVI and Moderna partner to tackle broad global health priorities using mRNA for vaccines and antibodies
IAVI | News Release | April 7, 2022

Trial of innovative HIV vaccine using mRNA technology enrolls first participant
HVTN | New Release | March 14, 2022

Translating the Language of Immunity
An advocate for equitable representation in science, doctoral student Nick Maurice was awarded the 2021 Graduate School Medal
UW Graduate School | May 26, 2021

People who have had COVID should get single vaccine dose, studies suggest
New studies show that one shot of a vaccine can greatly amplify antibody levels in those who have recovered from the coronavirus.
New York Times | Feb. 19, 2021

Black volunteers give COVID-19 vaccine trials a shot in the arm
Study participant discusses the importance of diversity in the COVID-19 trials.
Seattle Times | Dec. 14, 2020

Bonney Lake woman in COVID-19 vaccine trial says mild side effects are worth it
Volunteer participating in the AstraZeneca COVID-19 vaccine trials talks about mild symptoms.
KING5 | Dec. 10, 2020

Covid vaccines are coming soon, but must overcome public's safety doubts
Dr. Julie McElrath is interviewed about the Moderna and Pfizer vaccines.
Puget Sound Business Journal | Dec. 1, 2020

Despite hopeful vaccine news, Thanksgiving warnings remain dire
Dave Ross and Aaron Granillo chat with Dr. Julie McElrath about the early results of the Pfizer vaccine trial.
KIRO Radio | Nov. 12, 2020

Russia’s claim of a successful COVID-19 vaccine doesn’t pass the ‘smell test,’ critics say
Dr. Julie McElrath shares her concerns on the AD5 vector.
Science | Nov. 11, 2020

Roll Up Your Sleeve to Fight COVID-19: Three New Vaccine Trials Will Start Soon in the Seattle Area
Dr. Julie McElrath is interviewed about her vaccine study>
The Daily Chronical | Nov. 9, 2020

Seattle vaccine researchers react to Pfizer, still need volunteers
Dr. Julie McElrath talks about the phase 3 Astra Zeneca trials that she is leading.
KIRO 7 | Nov. 9, 2020

Pfizer’s COVID-19 vaccine shows promise, but don’t expect it in pharmacy anytime soon
Drs. Julie McElrath and Anna Wald are interview about AstraZeneca entering phase 3 human trial and the need for volunteers.
Q13 Fox | Nov. 9, 2020

Immunology institute founded by Paul Allen shifts focus to tackle coronavirus
Dr. Julie McElrath discussed the benefits of working with the Allen Institute for COVID-19 research.
The Seattle Times | Aug. 15, 2020

Fred Hutch and Allen Institute launch study of milder COVID-19 cases, aiming for unique insights
Dr. Julie McElrath’s work with the Allen Institute to understand the characteristics of an effective COVID-19 immune response was covered by GeekWire. 
GeekWire | Aug. 13, 2020

Everett Firefighters joining Fred Hutch COVID-19 study
Fred Hutch researchers tested firefighters for active COVID-19 to understand first responders exposure
KIRO7 | August 3, 2020

Fred Hutch studies immune response to COVID-19 needs participants
Dr. Julie McElrath is recruiting volunteers who have had coronavirus to look at immune response.
KIRO7 | June 28, 2020

Find more stories about Fred Hutch research on COVID-19